Skip to content
MedsAcross

Medicine

Glipizide 10 mg extended-release tablet

Glipizide · Oral
Available on requestPrescription onlyUS FDAGeneric name

Glipizide 10 mg extended-release tablet is a generic prescription medicine for oral use, made by 9 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F). The tablets should be protected from…

Key facts

Active ingredient (INN)
Glipizide
Brand
Sold under the generic name
Strength
10 mg
Dosage form
Extended-release tablet
Route
Oral
Packs
100 tablets, 500 tablets, 30 tablets and 41 more
Manufacturers
Aurobindo PharmaIndiaBryant Ranch PrepackA-S Medication SolutionsNorthwind HealthRemedyrepackRising Pharma HoldingsNorthStar RxPreferred Pharmaceuticals9 labelers on the register
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F). The tablets should be protected from moisture and humidity.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
A10BB07 Glipizide
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
24 April 2017
Identifiers
RxCUI 315107, 310489, 314006DailyMed set ID 0effd04d-172c-5d8c-e063-6294a90a93f4, 4982f018-c53c-48ec-a4e8-4834228bcf2c, e593552f-9817-4cb5-b491-31ea57dea4b8 +14NDC 82868-035, 50090-5806, 70518-3896 +14Application ANDA206928, ANDA204720, ANDA203499

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

A sample of 40 packs from 9 labelers. The register lists 44 packs for this generic presentation, and we confirm the exact pack on the quote.

PackCodeLabelerMarketed since
100 tablet, extended release in 1 bottle59651-782-01Aurobindo PharmaIndia3 March 2023
500 tablet, extended release in 1 bottle59651-782-05Aurobindo PharmaIndia3 March 2023
30 tablet, extended release in 1 bottle59651-782-30Aurobindo PharmaIndia3 March 2023
1000 tablet, extended release in 1 bottle59651-782-99Aurobindo PharmaIndia3 March 2023
100 tablet, film coated, extended release in 1 bottle, plastic64980-281-01Rising Pharma Holdings24 April 2017
500 tablet, film coated, extended release in 1 bottle, plastic64980-281-05Rising Pharma Holdings24 April 2017
1000 tablet, film coated, extended release in 1 bottle, plastic64980-281-10Rising Pharma Holdings24 April 2017
30 tablet, film coated, extended release in 1 bottle50090-5806-0A-S Medication Solutions15 October 2021
60 tablet, film coated, extended release in 1 bottle50090-5806-1A-S Medication Solutions15 October 2021
90 tablet, film coated, extended release in 1 bottle50090-5806-2A-S Medication Solutions15 October 2021
30 tablet, extended release in 1 bottle50090-6765-0A-S Medication Solutions19 October 2023
60 tablet, extended release in 1 bottle50090-6765-1A-S Medication Solutions19 October 2023
90 tablet, extended release in 1 bottle50090-6765-2A-S Medication Solutions19 October 2023
30 tablet, extended release in 1 bottle50090-6848-0A-S Medication Solutions29 November 2023
60 tablet, extended release in 1 bottle50090-6848-1A-S Medication Solutions29 November 2023
90 tablet, extended release in 1 bottle50090-6848-2A-S Medication Solutions29 November 2023
90 tablet, extended release in 1 bottle50090-6849-0A-S Medication Solutions29 November 2023
30 tablet, film coated, extended release in 1 bottle71335-1130-1Bryant Ranch Prepack6 March 2019
60 tablet, film coated, extended release in 1 bottle71335-1130-2Bryant Ranch Prepack6 March 2019
100 tablet, film coated, extended release in 1 bottle71335-1130-3Bryant Ranch Prepack6 March 2019
90 tablet, film coated, extended release in 1 bottle71335-1130-4Bryant Ranch Prepack6 March 2019
180 tablet, film coated, extended release in 1 bottle71335-1130-5Bryant Ranch Prepack6 March 2019
30 tablet, extended release in 1 bottle71335-2353-1Bryant Ranch Prepack21 February 2024
60 tablet, extended release in 1 bottle71335-2353-2Bryant Ranch Prepack21 February 2024
100 tablet, extended release in 1 bottle71335-2353-3Bryant Ranch Prepack21 February 2024
90 tablet, extended release in 1 bottle71335-2353-4Bryant Ranch Prepack21 February 2024
180 tablet, extended release in 1 bottle71335-2353-5Bryant Ranch Prepack21 February 2024
100 tablet, extended release in 1 bottle72162-2614-1Bryant Ranch Prepack20 April 2026
500 tablet, extended release in 1 bottle72162-2614-5Bryant Ranch Prepack20 April 2026
90 tablet, film coated, extended release in 1 bottle, plastic70518-1848-0Remedyrepack4 February 2019
30 tablet, film coated, extended release in 1 blister pack70518-1848-1Remedyrepack13 August 2019
30 tablet, extended release in 1 blister pack70518-3896-0Remedyrepack17 October 2023
90 tablet, extended release in 1 bottle, plastic70518-4128-1Remedyrepack8 September 2025
90 tablet, film coated, extended release in 1 bottle, plastic51655-966-26Northwind Health31 July 2023
30 tablet, film coated, extended release in 1 bottle, plastic51655-966-52Northwind Health27 June 2023
30 tablet, extended release in 1 bottle, plastic82868-035-30Northwind Health9 January 2024
90 tablet, extended release in 1 bottle, plastic82868-035-90Northwind Health15 February 2024
100 tablet, extended release in 1 bottle16714-896-01Northstar Rx1 December 2018
500 tablet, extended release in 1 bottle16714-896-02Northstar Rx1 December 2018
100 tablet, film coated, extended release in 1 bottle, plastic68788-7856-1Preferred Pharmaceuticals29 January 2021

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 8 May 1984Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Glipizide

Clinical summary

Glipizide is a sulfonylurea indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is available as tablets and extended-release tablets for oral use. MedsAcross supplies Glipizide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Glipizide

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Glipizide 10 mg extended-release tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.